Carbon Solutions Now and Next: From Biomass to Mineralization
The a16z Show13 Des 2022

Carbon Solutions Now and Next: From Biomass to Mineralization

In this episode, we tackle three carbon removal projects of varying scale, business models, and technical challenges.

  • Biomass pyrolysis via Charm Industrial
  • An electrochemical process via Travertine
  • Mineralization via 44.01

We cover these companies through the lens of their founders – Peter Reinhardt (CEO of Charm Industrial), Laura Lammers (CEO of Travertine), and Karan Khimji (COO of 44.01) – who share the fascinating stories of how they stumbled into this industry, how their processes work, whether they can economically scale, and ultimately why each of them is dedicating their time and energy to this field.

This episode also closes out our carbon removal mini series, where we’ve seen a unique convergence of attention, capital, policy, and creativity being applied. With that combination, it's rare that humans don't surprise one another in progress.

Resources:

Charm Industrial:

Travertine:

44.01:

Stay Updated:

Find us on Twitter: https://twitter.com/a16z

Find us on LinkedIn: https://www.linkedin.com/company/a16z

Subscribe on your favorite podcast app: https://a16z.simplecast.com/

Follow our host: https://twitter.com/stephsmithio

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. For more details please see a16z.com/disclosures.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1000)

Turning Open Source Developers Into Superfans

Turning Open Source Developers Into Superfans

In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform that people not only use, but t...

10 Aug 202045min

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of ta...

9 Aug 202018min

Working, Making, Creating in Public... and Private

Working, Making, Creating in Public... and Private

We're living in an unprecedented era of online collaboration, coordination, and creation. All kinds of people are coming together -- whether in an open source project or company, an R&D initiative, a ...

2 Aug 202047min

GPT-3: What's Hype, What's Real on the Latest in AI

GPT-3: What's Hype, What's Real on the Latest in AI

In this episode -- cross posted from our 16 Minutes show feed -- we cover all the buzz around GPT-3, the pre-trained machine learning model from OpenAI that’s optimized to do a variety of natural-lang...

30 Jul 202033min

Taking the Pulse on Medical Device Security

Taking the Pulse on Medical Device Security

Many don’t realize we even need to think about the possibility of security hacks when it comes to things like pacemakers, insulin pumps, and more. But when bits and bytes meet flesh and blood, securit...

22 Jul 202023min

Journal Club: A New Path to Antibiotic Resistance

Journal Club: A New Path to Antibiotic Resistance

Ever since the discovery of antibiotics, microbiologists have worried about and studied how bacteria acquire resistance to these drugs. Adding to the complexity of this problem is the fact that it is ...

19 Jul 202017min

Cybercrime, Incorporated

Cybercrime, Incorporated

A dive into the sociological, operational, and tactical realities of this murky underworld, Lusthaus and de la Garza discuss who the players are, what they are motivated by, and specialize in—as well ...

18 Jul 202036min

How Transparent Pricing Drives Healthcare Change

How Transparent Pricing Drives Healthcare Change

Dr. Marty Makary—surgical oncologist at Johns Hopkins University School of Medicine, and health policy and innovation expert—has long been a passionate advocate for transparent pricing in the healthca...

15 Jul 202029min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
finansredaksjonen
morgenkaffen-med-finansavisen
livet-pa-veien-med-jan-erik-larssen
utbytte
rss-sunn-okonomi
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
okonomiamatorene
lederpodden
rss-markedspuls-2
liberal-halvtime
arcticpodden